Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125921631 | 12592163 | 1 | I | 20160712 | 20160726 | 20160726 | EXP | BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-120692 | RANBAXY | LANOY C, BOUCKAERT Y. METABOLIC ACIDOSIS AND 5-OXOPROLINURIA INDUCED BY FLUCLOXACILLIN AND ACETAMINOPHEN: A CASE REPORT. J MED CASE REP. 2016;10 (1) | 82.00 | YR | F | Y | 0.00000 | 20160726 | OT | BE | BE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125921631 | 12592163 | 1 | SS | Flucloxacillin | FLUCLOXACILLIN | 1 | Unknown | UNK | Y | 0 | |||||||||
| 125921631 | 12592163 | 2 | PS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | UNK | Y | 76200 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125921631 | 12592163 | 1 | Product used for unknown indication |
| 125921631 | 12592163 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125921631 | 12592163 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125921631 | 12592163 | Metabolic acidosis | |
| 125921631 | 12592163 | Pyroglutamate increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |